German HealthTech firm Aiomics has efficiently closed a €2 million pre-Seed financing spherical to broaden its platform, scale to numerous care settings and put together for entry into further European markets.
The spherical was led by Vorwerk Ventures, with participation from Calm/Storm, Norrsken Evolve, and Rule30. A number of famend enterprise angels additionally joined the spherical, together with Konstantin Othmer, Nicolas Weber, Andrea Kranzer and Markus Wild.
“The medical software program panorama is present process a basic transformation: synthetic intelligence is driving the unbundling of present methods. In contrast to conventional software program, AI can adapt way more granularly to the person realities of various hospitals, departments, and specialties. This permits options like Aiomics to combine quicker and extra seamlessly – with huge potential for European healthcare,” mentioned Sascha Günther, Associate at Vorwerk Ventures.
Aiomics was based in 2025 by Dr Sven Jungmann, Dr Nikita Tarasov, and Kirill Schitomirski. The corporate is working with (as of but unannounced) main healthcare establishments.
Aiomics’ mission is to alleviate the healthcare system by decreasing administrative overhead and supporting the every day work of clinicians, nurses, and therapists with validated, structured, and workflow-guiding knowledge.
Aiomics develops an AI-powered documentation platform for healthcare designed to alleviate medical doctors, nurses, and therapists from time-consuming administrative work. The answer captures speech, handwriting, and paperwork in a single validated workflow, checks completeness and consistency by way of a human-in-the-loop course of, and delivers structured, coded, and audit-secure knowledge again into present methods.
This allegedly reduces errors, accelerates reimbursements, and frees medical employees to focus extra on affected person care.
With the contemporary capital, Aiomics plans to additional broaden its platform, scale to numerous care settings – from acute hospitals and rehabilitation facilities to telemedicine suppliers – and put together for entry into further European markets.
Aiomics’ funding spherical was included in EU-Startups’ coverage of Norrsken Evolve; a €57 million fund aimed toward investing in early-stage, impact-driven firms throughout Europe. Aiomics was amonth the portfolio firms introduced with the fund.
